Literature DB >> 12627662

Activated protein C resistance (FV(Leiden)) and thrombosis: factor V mutations causing hypercoagulable states.

Gerry A F Nicolaes1, Björn Dahlbäck.   

Abstract

The integrity of the vascular system is of prime importance for survival. Therefore, several emergency and repair systems safeguard the circulatory system. Multiple processes jointly limit vascular damage and blood loss. In this article, the authors focus on the protein C anticoagulant pathway and the role of activated protein C resistance in thrombotic disease, and they discuss the involvement in thrombosis of mutations other than the Arg506Gln mutation in the gene encoding for factor V.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12627662     DOI: 10.1016/s0889-8588(02)00097-7

Source DB:  PubMed          Journal:  Hematol Oncol Clin North Am        ISSN: 0889-8588            Impact factor:   3.722


  7 in total

Review 1.  Antithrombotic therapy for stroke in young adults.

Authors:  Jeremy R Payne; Bruce Coull
Journal:  J Thromb Thrombolysis       Date:  2005-10       Impact factor: 2.300

2.  Thrombin generation profiles in deep venous thrombosis.

Authors:  K E Brummel-Ziedins; C Y Vossen; S Butenas; K G Mann; F R Rosendaal
Journal:  J Thromb Haemost       Date:  2005-11       Impact factor: 5.824

3.  The plasma hemostatic proteome: thrombin generation in healthy individuals.

Authors:  K Brummel-Ziedins; C Y Vossen; F R Rosendaal; K Umezaki; K G Mann
Journal:  J Thromb Haemost       Date:  2005-07       Impact factor: 5.824

4.  Factor V-Leiden Mutation: A Common Risk Factor for Venous Thrombosis among Lebanese Patients.

Authors:  Raghid Kreidy
Journal:  Thrombosis       Date:  2012-06-12

5.  A case report of a new pulmonary embolism occurring in a patient receiving continuous infusion of recombinant activated protein C.

Authors:  Bernard J Benedetto; Michael A Houston
Journal:  World J Emerg Surg       Date:  2006-08-09       Impact factor: 5.469

6.  Effects of exogenous recombinant APC in mouse models of ischemia reperfusion injury and of atherosclerosis.

Authors:  Karin C A A Wildhagen; Roy Schrijver; Linda Beckers; Hugo ten Cate; Chris P M Reutelingsperger; Esther Lutgens; Gerry A F Nicolaes
Journal:  PLoS One       Date:  2014-07-17       Impact factor: 3.240

7.  To determine the frequency of Factor V Leiden in cases of Deep Vein Thrombosis and Healthy controls.

Authors:  Anjum Saeed; Muhammad Ali Kashif
Journal:  Pak J Med Sci       Date:  2015 Sep-Oct       Impact factor: 1.088

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.